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Summary: Phospholipase A2 has been implicated in the pathogenesis of local and distant tissue injury after isch-
aemia and reperfusion. A common operation inducing ischaemia and reperfusion is aortobifemoral reconstruction,
during which the aorta is clamped and the blood supply via the inferior mesenteric artery and iliac arteries is
interrupted. The purpose of the present work was to study the catalytic activity concentration of phospholipase A2
and the mass concentrations of group I and group II phospholipases A2 in the sera of patients undergoing aortobi-
femoral reconstruction. Both the catalytic activity concentration of phospholipase A2 and the mass concentrations
of group I and group II phospholipases A2 increased in serum samples after the operation. The catalytic activity
concentration of phospholipase A2 correlated well with group II phospholipase A2 mass values (r = 0.81,
p < 0.001), whereas no correlation was found between the catalytic activity concentration of phospholipase A2 and
group I phospholipase A2 mass values (r = 0.12, p = 0.54). The results emphasize the role of group II phospholi-
pase A2 in tissue injury after ischaemia and reperfusion.
Introduction
Phospholipases are hydrolytic enzymes widespread in
nature. Phospholipids are the main lipid constituents of
all cell membranes and phospholipases control a number
of vital cell functions including membrane and cell in-
tegrity, signal transduction, secretion, prostaglandin syn-
thesis and cell proliferation (1-5). Phospholipase A2 is
an enzyme of considerable interest with regard to the
pathogenesis of various diseases, since its reaction pro-
ducts, lysophospholipids and non-esterified fatty acids,
are highly cytotoxic substances (6).
Phospholipase A2 has been postulated to be involved
in the development of tissue injury after ischaemia and
reperfusion (7-11). Phospholipase A2 inhibitors effec-
tively decrease local (7, 12) and distant (10) tissue dam-
age after ischaemia and reperfusion.
Secretory, small molecular mass (Afr 14000) phospholi-
pases A2 can be divided into group I phospolipases A2
and group II phospholipases A2 based on their amino
acid sequences (13). The recent development of specific
immunoassays of group I and group II phospholipases
A2 significantly contributed to studies on the role(s) of
these enzymes in various diseases. The best charac-
terized function of group I phospholipase A2 is digestion
of the phospholipid component of dietary fat (14), but
the enzyme also functions as a growth factor (1) and
vasoactive substance (15), and stimulates prostaglandin
synthesis (16). Group II phospholipase A2 is involved in
the inflammatory reaction (17), but the details of the
role of group II phospholipase A2 are unknown. The
amount of group II phospholipase A2 is markedly
increased in serum during infection and inflammation
(17, 18), and the enzyme may function in defence
against bacteria (19). Very high levels of circulating
group II phospholipase A2 are associated with sepsis,
and a pivotal role was recently postulated for group II
phospholipase A2 in the pathogenesis of circulatory col-
lapse in septic shock (20). The source of group I phos-
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pholipase A2 found in serum is the pancreas, whereas
the source of group II phospholipase A2 is unknown.
Further, it is not known which of these secretory phos-
pholipases A2 is responsible for the increased catalytic
activity concentration of phospholipase A2 in serum af-
ter ischaemia and reperfusion. It has been hypothesized
that activated pancreatic digestive enzymes such as
group I phospholipase A2 may play an important role in
ischaemic intestinal injury by digesting various struc-
tures of mucosal cells (21).
A common operation inducing ischaemia and reperfu-
sion in the descending colon and lower extremities is
aortobifemoral reconstruction, during which the blood
supply via the inferior mesenteric artery and iliac arter-
ies is interrupted. The purpose of the present work was
to study the catalytic activity concentration of phospho-
lipase A2 and the mass concentrations of group I and
group II phospholipases A2 in sera of patients under-
going aortobifemoral reconstruction. Specifically, the
questions to be answered were: Does the catalytic activ-
ity concentration of phospholipase A2 change in sera of
patients undergoing aortobifemoral reconstruction?
Which one of the secretory phospholipases A2 (group I
or II) is involved?
Patients and Methods
Ten consecutive patients undergoing aortobifemoral reconstruction
with Y-prosthesis for aortoiliacal occlusive disease (n = 8) or aor-
tic aneurysm (n = 2) in the University Central Hospital of Turku
were enrolled in the present study. The mean age of the patients
was 55 (range 45—69) years and there were six females and four
males. The study was approved by the local Ethical Committee and
an informed consent was obtained from each patient.
The Y-prosthesis was anastomosed end-to-end to the aorta below
the origins of renal arteries and the distal anastomoses were recon-
structed during the same aortic cross-clamp. The inferior mesen-
teric artery was ligated at its origin from the aorta in patients with
aortic aneurysm, whereas the blood flow to the inferior mesenteric
artery was established at reperrusion via the stenotic iliac arteries
in patients operated for arteriosclerotic disease.
The operations were performed under general anaesthesia with
thiopentone, pancuronium, fentanyl, dehydrobenzperidol, enflurane
(volume fraction 0.005-0.01) and nitrous oxide (volume fraction
0.70) plus oxygen (volume fraction 0.30). The patients had a cathe-
ter inserted into a radial artery for haemodynamic monitoring. End-
tidal CO2 was monitored and kept at a level of normoventilation
(4.5-5.5 kPa). Blood loss was replaced with Ringer's acetate solu-
tion and with packed red blood cells, when necessary, to maintain
the blood haemoglobin concentration above 100 g/1. After the oper-
ation, atropine and neostigmine were used to reverse the neuromus-
cular blockade and the patients were extubated in the operating
room. The mean blood loss was 1400 (range 100-5800) ml, opera-
tion time 161 (125-185) min, aortic clamping time 61 (39-106)
min and the deepest fall in blood pressure after aortic declamping
37 (10-75) mmHg. All the patients recovered uneventfully.
Blood samples were withdrawn before the operation, before aortic
clamping, after declamping, three and six hours after declamping,
and thereafter daily until the eighth postoperative day to determine
the catalytic activity concentration of phospholipase A2 and the
mass concentrations of group I and group II phospholipases A2 in
serum. The catalytic activity concentration of phospholipase A2
was assayed by using micellar radioactive phosphatidylcholine as
a substrate (22). The mass concentrations of group I and group II
phospholipases A2 were measured by time-resolved fluoroimmu-
noassays as described earlier (23, 24). The serum samples were
stored at -20 °C until assayed.
The results are expressed as mean ± SUM. The significance of
the time-related changes was tested by the analysis of variance
(ANOVA) with repeated measurements. Newman-Keuls' multiple
range test was used to test differences between the preoperative
and other values. Pearson's linear correlation was used to study
















Fig. 1 Group I phospholipase A2, group II phospholipase A2
mass concentration and the catalytic activity concentration of phos-
pholipase A2 in sera of ten consecutive patients undergoing aorto^
bifemoral reconstruction (mean ± SEM). * p < 0.05 and
**p,<0.01 compared with the preoperative values (Newman-
Keuls' multiple range test).
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phospholipase A2 and the mass concentrations of group I and
group II phospholipase A2.
Results
Figure 1 shows the mass concentrations of group I and
group II phospholipases A2 and the catalytic activity
concentration of phospholipase A2 in sera of the oper-
ated patients. The mass concentrations of group I and
group II phospholipases A2 and the catalytic activity
concentration of phospholipase A2 increased steadily
during days 1—4 after the operation and decreased
thereafter (p < 0.001). The mass concentration of
group II phospholipase A2 and the catalytic activity con-
centration of phospholipase A2 changed in concert and
reached in their peak values on the fourth postoperative
day, while the mass concentration of group I phospholi-
pase A2 reached its maximum at the second postopera-
tive day. The patients did not show any clinical signs of
postoperative pancreatitis.
The catalytic activity concentration of phospholipase A2
correlated well with the mass concentration of group II
phospholipase A2 in the regression analysis (fig. 2;
r = 0.81, p < 0.001), whereas there was no correlation
between the catalytic activity concentration of phospho-
lipase A2 and the mass concentration of group I phos-
pholipase A2 (fig. 3; r = 0.12, p = 0.54).
Discussion
Increased phospholipase A2 activity seems to be instru-
mental for the development of ischaemic intestinal in-
jury (11). Phospholipase A2 inhibitors effectively
decrease tissue damage and the increase in mucosal per-
meability in experimental intestinal ischaemia (7, 12).
Moreover, increase of phospholipase A2 activity is re-
garded a crucial step in the pathogenesis of distant organ
injury after ischaemia and reperfusion, since phospho-
lipase A2 inhibition prevented lung injury after isch-
aemia and reperfusion of the gut (10). Phospholipase
A2 is involved in the generation of a variety of bio-
active and potentially toxic lipid metabolites, such as
arachidonic acid metabolites, lysophospholipids, and
platelet-activating factor (6), which may play a role
in local and distant tissue injury after ischaemia and
reperfusion. In addition, damage at the mucosal layer
of the intestine allows enhanced uptake of bacteria
and endotoxins from the intestinal lumen into circula-
tion (25), which, in turn, increases the formation of
inflammatory mediators such as phospholipase A2
leading to a decrease in blood pressure and circulation
(20). These changes may create a vicious circle in
which impaired intestinal perfusion leads to a pro-
gressive damage of intestinal mucosal cells resulting
ultimately in bowel infarction. In aortobifemoral re-
construction, the blood supply from the inferior mes-
enteric artery is interrupted, and, thus, this operation
always induces left colonic ischaemia to some extent.
Although the resulting ischaemic colonic injury usually
runs a benign course, a fulminant disease develops in
a minority of patients. This may prove fatal in spite
of prompt surgical intervention. The results of the
current study emphasize the role of group II phospho-
lipase A2 in tissue injury after ischaemia and reperfu-
sion.
The mass concentration of group I phospholipase A2
increased in sera of patients after aortobifemoral recon-
struction in the current study, but no clinical signs of
postoperative pancreatitis were noticed. The slight
increase in serum group I phospholipase A2 mass con-
centration may be due to pancreatic irritation during the
operation. Group I phospholipase A2 mass concentration
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Fig. 2 Linear regression between the catalytic activity concentra- Fig. 3 Linear regression between the catalytic activity concentra-
tion of phospholipase A2 and the mass concentration of group II tion of phospholipase A2 and the mass concentration of group I
phospholipase A2 in sera of patients undergoing aortobifemoral re- phospholipase A2 in sera of patients undergoing aortobifemoral re-
construction (r = 0.81, p < 0.001). construction (r = 0.12, p = 0.54).
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centration of phospholipase A2^The results of the cur-
rent study do not support the formerly presented idea
(21) that activated/increased pancreatic digestive en-
zymes such as group I phospholipase A2 may play an
important role in ischaemic intestinal injury.
The current results show that the catalytic activity con-
centration of phospholipase A2 and the mass concentra-
tions of group I and group II phospholipases A2 increase
in sera of patients after aortobifemoral reconstruction.
The catalytic activity concentration of phospholipase A2
correlates well with the mass concentration of group II
phospholipase A2 but not with the mass concentration
of group I phospholipase A2 in sera of these patients.
These results indicate that the increase in the catalytic
activity concentration of phospholipase A2 is due to
group II phospholipase A2. We conclude that group II
phospholipase A2 may be involved in the development
of local and distant tissue injury after ischaemia and re-
perfusion. f
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